​Greg brings clarity to complexity, helping biopharma leaders make confident, well-informed decisions when the stakes are highest. He advises executive teams through inflection points that shape enterprise direction, portfolio value, and sustained growth.

​Greg is a thought partner and leader within the Digital and Commercial space. He partners with executive teams to turn AI ambition into enterprise value, setting their strategic narrative and direction, builds the operating infrastructure to execute, and ensures solutions are adopted in day-to-day workflows with measurable performance impact. His Commercial expertise includes new product planning, portfolio strategy, search and evaluation, business development, and launch. Regardless of his partnership, Greg drives principles of operational excellence across all his engagements.

​His previous experiences at L.E.K. Consulting, Blue Matter, FundRx, and Perelman School of Medicine’s Neurosurgery department brings a cross-disciplinary background across strategy consulting, venture investing, and translational research. These experiences have shaped his analytical rigor and pragmatic execution across how he engages his clients.

​Measured, insightful, and precise, Greg’s work helps biopharma organizations think smarter, move faster, and lead with confidence.